Treace Medical Concepts (TMCI) News Today $6.62 -0.14 (-2.07%) Closing price 04:00 PM EasternExtended Trading$6.63 +0.01 (+0.15%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud LawsuitApril 15 at 3:08 PM | prnewswire.comRosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsApril 15 at 12:02 PM | businesswire.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (TMCI)April 14 at 8:00 PM | globenewswire.com65,800 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Norges BankNorges Bank bought a new stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 65,800 shares of the company's stock, valued at approximately $490,000. NApril 14 at 3:29 AM | marketbeat.comJPMorgan Chase & Co. Increases Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)JPMorgan Chase & Co. lifted its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 56.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,977,219 shares of the company's stock after acquApril 14 at 3:29 AM | marketbeat.comTruist Financial Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $8.00April 14 at 1:45 AM | americanbankingnews.comScott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)April 13 at 12:30 PM | globenewswire.comTMCI Investors Have the Opportunity to Lead the Treace Medical Concepts Securities Fraud Lawsuit with Faruqi & Faruqi, LLPApril 13 at 12:25 PM | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Price Target Lowered to $8.00 at Truist FinancialTruist Financial dropped their price target on shares of Treace Medical Concepts from $9.50 to $8.00 and set a "hold" rating for the company in a research report on Friday.April 13 at 9:54 AM | marketbeat.comTreace Medical price target lowered to $8 from $9.50 at TruistApril 12 at 1:59 AM | markets.businessinsider.comScott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)April 11, 2025 | businesswire.comScott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)April 11, 2025 | globenewswire.com52,742 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 52,742 shares of the company's stock, valued at approximatelyApril 10, 2025 | marketbeat.comTreace Medical appoints John Treace as chairman of the boardApril 7, 2025 | markets.businessinsider.comTreace Medical Concepts: No Solid FootingApril 7, 2025 | seekingalpha.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Decrease in Short InterestTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 2,240,000 shares, a drop of 17.9% from the February 28th total of 2,730,000 shares. Based on an average daily trading volume, of 392,100 shares, the short-interest ratio is presently 5.7 days. Currently, 5.0% of the company's shares are sold short.April 2, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Hold" from AnalystsShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and two have assignedMarch 30, 2025 | marketbeat.comTreace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific ConferenceMarch 28, 2025 | globenewswire.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. decreased its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 10.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 349,510 shares ofMarch 28, 2025 | marketbeat.comTreace Highlights New Innovations at the 2025 ACFAS Annual Scientific ConferenceMarch 25, 2025 | globenewswire.com45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 45,923 shares of the company's stock, valuMarch 24, 2025 | marketbeat.comInsider Selling: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sells 50,000 Shares of StockTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) insider Sean F. Scanlan sold 50,000 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $7.97, for a total transaction of $398,500.00. Following the completion of the sale, the insider now directly owns 364,081 shares of the company's stock, valued at $2,901,725.57. The trade was a 12.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 20, 2025 | marketbeat.comSean F. Scanlan Sells 50,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) StockMarch 20, 2025 | insidertrades.comTreace Medical Concepts (NASDAQ:TMCI) Stock Price Up 4.7% - Should You Buy?Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% Higher - Should You Buy?March 19, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest UpdateTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 2,730,000 shares, a growth of 20.8% from the February 13th total of 2,260,000 shares. Currently, 6.1% of the company's stock are sold short. Based on an average daily volume of 373,500 shares, the short-interest ratio is currently 7.3 days.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Has $21.87 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)William Blair Investment Management LLC grew its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,938,8March 19, 2025 | marketbeat.comTruist Financial Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock PriceTruist Financial dropped their price target on Treace Medical Concepts from $10.00 to $9.50 and set a "hold" rating on the stock in a research note on Thursday.March 14, 2025 | marketbeat.comJohn Treace Spends US$524k On Treace Medical Concepts StockMarch 9, 2025 | finance.yahoo.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's WhyTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's WhyMarch 6, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Hold" by BrokeragesShares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus rating of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and two have assigned a buyMarch 4, 2025 | marketbeat.comTruist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)March 3, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Given New $10.00 Price Target at Truist FinancialTruist Financial lifted their price objective on shares of Treace Medical Concepts from $8.40 to $10.00 and gave the company a "hold" rating in a research note on Monday.March 3, 2025 | marketbeat.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | msn.comTreace Medical Concepts (TMCI) Receives a Hold from Morgan StanleyMarch 1, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Announces Earnings ResultsTreace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Treace Medical Concepts had a negative net margin of 30.33% and a negative return on equity of 51.12%.February 28, 2025 | marketbeat.comTreace Medical Concepts, Inc. (TMCI) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Treace Medical Concepts (TMCI) and Jasper Therapeutics (JSPR)February 27, 2025 | markets.businessinsider.comTreace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial ResultsFebruary 27, 2025 | markets.businessinsider.comTreace Medical Concepts (TMCI) Expected to Announce Quarterly Earnings on ThursdayTreace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)February 20, 2025 | marketbeat.comInsider Stock Buying Reaches US$7.31m On Treace Medical ConceptsFebruary 8, 2025 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by AnalystsTreace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendationFebruary 7, 2025 | marketbeat.comTreace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025February 6, 2025 | globenewswire.comWhy Treace Medical Concepts (TMCI) Is Rallying TodayFebruary 5, 2025 | msn.comTreace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Should You Buy?Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's What HappenedFebruary 4, 2025 | marketbeat.comTreace Medical upgraded to Buy from Neutral at BTIGFebruary 4, 2025 | markets.businessinsider.comBTIG raises Treace Medical stock to Buy, sets $16 targetFebruary 4, 2025 | msn.comPositive Report for Treace Medical Concepts (TMCI) from BTIGFebruary 4, 2025 | markets.businessinsider.comTreace Medical Concepts (NASDAQ:TMCI) Stock Rating Upgraded by BTIG ResearchBTIG Research raised shares of Treace Medical Concepts from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Tuesday.February 4, 2025 | marketbeat.comTreace Medical announces completion of first cases using SpeedAkin ACIJanuary 30, 2025 | markets.businessinsider.comTreace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression ImplantJanuary 30, 2025 | markets.businessinsider.com Remove Ads Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address TMCI Media Mentions By Week TMCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMCI News Sentiment▼0.320.80▲Average Medical News Sentiment TMCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMCI Articles This Week▼153▲TMCI Articles Average Week Remove Ads Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Enovis News NovoCure News LeMaitre Vascular News CONMED News Warby Parker News Cadre News Kestra Medical Technologies News Tandem Diabetes Care News Paragon 28 News InMode News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TMCI) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
